Food and Drug Administration

FDA Alerts Public to Philips Respironics Ventilator Correction Over In-Line Nebulizer Concerns

WASHINGTON, D.C. — The United States Food and Drug Administration has issued a crucial announcement concerning a voluntary correction by Philips Respironics regarding their Trilogy Evo series ventilators. This correction addresses …

FDA Alerts Public to Philips Respironics Ventilator Correction Over In-Line Nebulizer Concerns Read More